Get started
Author

Chris B. Russell

Observed names: C B Russell, C Russell, C.B. Russell, Chris B Russell, Chris B. RUSSELL, Chris Russel, Chris Russell, Christopher B. Russell
Observed institutions: University Hospitals Birmingham NHS Foundation Trust, Amgen (United States), Queen Mary University of London, University of Oregon, Guy's and St Thomas' NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust, Fred Hutch Cancer Center, University College London, Imperial College London, BioMarin (United States)
ORCID: 0000-0002-0240-1815
Observed ORCID: 0000-0002-0240-1815
OpenAlex ID: A5070208317
Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
2012 · Kim A. Papp, Craig Leonardi, et al. · New England Journal of Medicine · 937
The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses
2013 · Michelle A. Lowes, Chris B. Russell, et al. · Trends in Immunology · 538
A prospective phase III, randomized, double‐blind, placebo‐controlled study of brodalumab in patients with moderate‐to‐severe plaque psoriasis
2016 · K.A. Papp, K. Reich, et al. · British Journal of Dermatology · 471
PDF
The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings
2012 · David A. Martin, Jennifer E. Towne, et al. · Journal of Investigative Dermatology · 467
Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A
2020 · K. John Pasi, Savita Rangarajan, et al. · New England Journal of Medicine · 448
PDF
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Disease
2016 · Stephan R Targan, Brian Feagan, et al. · The American Journal of Gastroenterology · 383
Chromosomal transformation of Escherichia coli recD strains with linearized plasmids
1989 · C B Russell, D S Thaler, et al. · Journal of Bacteriology · 163
Gene Expression Profiles Normalized in Psoriatic Skin by Treatment with Brodalumab, a Human Anti–IL-17 Receptor Monoclonal Antibody
2014 · Chris B Russell, Hugh Rand, et al. · The Journal of Immunology · 161
Anti-IL-17 Receptor Antibody AMG 827 Leads to Rapid Clinical Response in Subjects with Moderate to Severe Psoriasis: Results from a Phase I, Randomized, Placebo-Controlled Trial
2012 · Kim A. Papp, Cathy Reid, et al. · Journal of Investigative Dermatology · 143
A Central Nervous System-Restricted Isoform of the Interleukin-1 Receptor Accessory Protein Modulates Neuronal Responses to Interleukin-1
2009 · Dirk E. Smith, Brian P. Lipsky, et al. · Immunity · 135
PDF
Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A
2022 · Sylvia Fong, Bridget Yates, et al. · Nature Medicine · 124
PDF
A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis
2013 · David A Martin, Melvin Churchill, et al. · Arthritis Research & Therapy · 108
PDF
Brief Report: Pharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti–Interferon‐γ Antibody, in Patients With Discoid Lupus Erythematosus
2017 · Victoria P. Werth, David Fiorentino, et al. · Arthritis & Rheumatology · 79
PDF
Extremely short 20–33 nucleotide introns are the standard length inParamecium tetraurelia
1994 · Chris B. Russell, Dean Fraga, et al. · Nucleic Acids Research · 79
Cross-Study Homogeneity of Psoriasis Gene Expression in Skin across a Large Expression Range
2013 · Jeannette Bigler, Hugh A. Rand, et al. · PLoS ONE · 76
Short-term transcriptional response to IL-17 receptor-A antagonism in the treatment of psoriasis
2019 · Lewis E. Tomalin, Chris B. Russell, et al. · Journal of Allergy and Clinical Immunology · 66
Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseases
2016 · Ajay Nirula, Jon Nilsen, et al. · Lara D. Veeken · 59
Exchange of chromosomal and plasmid alleles in Escherichia coli by selection for loss of a dominant antibiotic sensitivity marker
1989 · C B Russell, F W Dahlquist · Journal of Bacteriology · 50
Large-scale gene expression profiling reveals distinct type 2 inflammatory patterns in chronic rhinosinusitis subtypes
2016 · Matthew A. Tyler, Chris B. Russell, et al. · Journal of Allergy and Clinical Immunology · 49
PDF
Long‐term safety and efficacy outcomes of valoctocogene roxaparvovec gene transfer up to 6 years post‐treatment
2024 · Emily Symington, Savita Rangarajan, et al. · Haemophilia · 47
PDF
Prospective–Retrospective Biomarker Analysis for Regulatory Consideration: white Paper from the Industry Pharmacogenomics Working Group
2011 · Scott D Patterson, Nadine Cohen, et al. · Pharmacogenomics · 47
Cellular responses to individual amino‐acid depletion in antibody‐expressing and parental CHO cell lines
2013 · Dina Fomina‐Yadlin, John J. Gosink, et al. · Biotechnology and Bioengineering · 43
Distinguishing Molecular Features of Allergic Fungal Rhinosinusitis
2018 · Matthew A. Tyler, Caroline J. Padro Dietz, et al. · Otolaryngology · 41
Molecular analysis of AAV5-hFVIII-SQ vector-genome-processing kinetics in transduced mouse and nonhuman primate livers
2021 · Choong-Ryoul Sihn, Britta Handyside, et al. · Molecular Therapy — Methods & Clinical Development · 34
PDF
Neurofilament light is a treatment‐responsive biomarker in CLN2 disease
2019 · Yuanbin Ru, Carley Corado, et al. · Annals of Clinical and Translational Neurology · 31
PDF
Works count: 41
Citation count: 4,970
H-index: 27
I10-index: 33
Year
Topic
Type